Healthcare Growth MicroCare is strengthening its footprint in healthcare and regulated industries with ISO 10993 registrations, a regulatory affairs function, and dedicated healthcare sales leadership. This combination creates opportunities to sell cleaning, coating, and disinfection solutions to medical device manufacturers, contract manufacturers, hospitals, and clinical labs that require regulatory-compliant processes. Position as a partner for validated cleaning protocols, process optimization, and compliant product chemistries.
Diagnostics Engagement The Beyond Solvents initiative provides diagnostic guidance to diagnose persistent contamination in production. This opens a path for consulting-led engagements and pilots that showcase solvent alternatives and improved cleanliness, increasing win probability for core cleaning fluids, vapor degreasing fluids, and coatings. Use success stories to expand into adjacent markets and multi-site deployments.
Global Manufacturing MicroCare’s global manufacturing footprint enables multi-region supply, regional support, and faster delivery for electronics, fiber optics, medical devices, and aerospace customers. Highlight supply chain resilience, localized regulatory assistance, and the ability to standardize across sites to simplify procurement for global accounts and OEMs.
R&D Momentum New leadership in research and development signals ongoing product innovation and capability to co-develop custom formulations for challenging soils and regulatory constraints. Propose collaborative product development with key OEMs and contract manufacturers to create tailored cleaning, coating, or lubrication chemistries aligned with their processes and compliance programs.
Growth Funding Active private equity-backed growth and recent acquisitions indicate capital and strategic intent to scale. This environment supports larger pilot opportunities, long-term contracts, and supplier diversification for enterprise customers seeking a stable, innovative partner with a track record of expanding offerings through acquisitions and organic growth.